Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Infant Development
Total 0 results
Nothing found
Sponsors and Collaborators
Hospital Governador Celso Ramos
Centre Hospitalier du Quebec
Shaoxing Mashan Street Community Health Service Center
Sociedad Panameña de Hematología
MYOR Ltd.
Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation
Pompeyo Stalin Alarcón Vigil
Universidad Mayor de San Simón (UMSS, Bolivia)
Dr. Jochen Brack
Saw Swee Hock School of Public Health
Sub-Investigator: Łucja Bieleninik, PhD
Roongroj Bhidayasiri
Donald B. Kohn, M.D.
Nelson Mandela Academic Hospital
Worabe Comprehensive Specialiazed Hospital
Shenzhen Core Medical Technology CO.,LTD.
Steven B. Kleiboeker
Maria de las Mercedes Perez Rodriguez
Didem OZKAL EMINOGLU
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
View Full List
Medical Conditions
Pharmacokinetics of Ipragliflozin
Atherosclerosis Coronary Artery With Angina Pectoris
Neuroectodermal Tumor
Macrocephaly Autism Syndrome
Control Nausea and Vomiting
Inoperable Stage III Non-small Cell Lung Cancer
Urinary Bladder Neurogenic Dysfunction
Poor Medication Adherence
Root Abscess
Bladder Cancer Recurrent
Endoscopic Surveillance
Malignant Tumor of Urinary System (Disorder)
Small Intestine Cancer
Humerus Fracture Displaced Proximal
Memory Disorders
0.5-14 Year Old Children With Nephroblastoma
Granulomatous Disease, Chronic
Parental
Anticoagulant Prophylaxis/Therapy
Bladder Recurrence
View Full List
Drug Interventions
Vehicle
FTD regimen
Idelalisib
The drug "Rutan 0.1".
Varenicline Controlled Release 1.2 mg
SAR408701 (Tusamitamab ravtansine)
Cyclosporine A
Biphasic insulin aspart 30
Sparsentan
Salvinorin A
Campath 1H
Letrozole
Ceralasertib
Elafibranor 80mg
Everolimus
Clozapine 100 mg
APG2575 800 mg
Fibrin Sealant
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
Bupropion Extended Release Oral Tablet
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Bahrain
Contract Research Organizations in Denmark
Contract Research Organizations in Egypt
Contract Research Organizations in Germany
Contract Research Organizations in Greece
Contract Research Organizations in Indonesia
Contract Research Organizations in Macedonia
Contract Research Organizations in Mauritania
Contract Research Organizations in Saint Lucia
Contract Research Organizations in South Africa
Contract Research Organizations in United Arab Emirates
Contract Research Organizations in Venezuela
CRO list by country
CROs in Costa Rica
SGS
All CROs in Costa Rica
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe